'As required' medication regimens for seriously mentally ill people in hospital. 2007

A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
Malham House, Hyde Terrace, Leeds, UK. abhijitchakrabarti@yahoo.co.uk

BACKGROUND Drugs used to treat psychotic illnesses may take weeks to be effective. In the interim, additional 'as required' doses of medication can be used to calm patients in psychiatric wards. The practice is widespread with 20% - 50% of people on acute psychiatric wards receiving at least one 'as required' dose of psychotropic medication during their admission. OBJECTIVE To compare the effects of 'as required' medication regimens with regular regimens of medication for the treatment of psychotic symptoms or behavioural disturbance, thought to be secondary to psychotic illness. METHODS For this 2006 update, we searched The Cochrane Schizophrenia Group's register of trials (March 2006). METHODS We included all relevant randomised control trials involving hospital inpatients with schizophrenia or schizophrenia-like illnesses, comparing any regimen of medication administered for the short term relief of behavioural disturbance, or psychotic symptoms, to be given at the discretion of ward staff ('as required', 'prn') with fixed non-discretionary patterns of drug administration of the same drug(s). This was in addition to regular psychotropic medication for the long-term treatment of schizophrenia or schizophrenia-like illnesses where prescribed. METHODS We independently inspected abstracts, extracted data from the papers and quality assessed the data. For dichotomous data we would have calculated the relative risks (RR), with the 95% confidence intervals (CI) and the number needed to treat statistic (NNT). Analyses would have been conducted on an intention-to-treat basis. RESULTS We didn't identify any randomised trials comparing 'as required' medication regimens to regular regimens of the same drug. CONCLUSIONS There is no evidence from within randomised trials to support this common current practices. Current practice is based on clinical experience and habit rather than high quality evidence.

UI MeSH Term Description Entries
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
May 2008, Journal of advanced nursing,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
December 2015, The Cochrane database of systematic reviews,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
January 2002, The Cochrane database of systematic reviews,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
January 1993, The Milbank quarterly,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
November 2015, Psychiatrische Praxis,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
July 1995, Journal of psychosocial nursing and mental health services,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
January 1994, The Journal of nervous and mental disease,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
March 1996, Psychiatric services (Washington, D.C.),
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
January 1987, New directions for mental health services,
A Chakrabarti, and E Whicher, and M Morrison, and P Douglas-Hall
June 1992, American journal of public health,
Copied contents to your clipboard!